Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08GOD
|
|||
| Drug Name |
Tradipitant
|
|||
| Synonyms |
Tradipitant; 622370-35-8; LY-686017; VLY-686; UNII-NY0COC51FI; LY686017; NY0COC51FI; Tradipitant [USAN:INN]; Tradipitant(VLY-686); SCHEMBL2898629; GTPL9278; CHEMBL3544984; CAVRKWRKTNINFF-UHFFFAOYSA-N; BCP30446; ZINC43194077; DB12580; SB18893; CS-8056; HY-16732; DA-31788; AS-35293; FT-0703806; Tradipitant
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 3 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H16ClF6N5O
|
|||
| Canonical SMILES |
C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl
|
|||
| InChI |
1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2
|
|||
| InChIKey |
CAVRKWRKTNINFF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 622370-35-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04326426) ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.